Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6-8
pubmed:dateCreated
2008-11-25
pubmed:abstractText
The purpose of the present study was to determine whether the flavonoid, baicalin is effective at blunting the negative influence of ischemia/reperfusion to the rat retina in situ and of various insults to a transformed retinal ganglion cells (RGC-5 cells) in culture. Baicalin was administered intraperitoneally just before and after an ischemic insult to retina of one eye of a rat. Ischemia was delivered by raising the intraocular pressure above the systolic blood pressure for 50min. Seven days after ischemia, retinas were analysed for the localisation of various antigens. Retinal extracts were also analysed for various mRNAs. Moreover, the content of specific proteins was deduced in retinal and optic nerve extracts. Also, RGC-5 cells in culture were given one of three different insults, light (1000lx for 2 days), hydrogen peroxide (200microM H(2)O(2) for 24h) or serum deprivation (48h) where cell survival and reactive oxygen species (ROS) formation was assayed. Moreover, a lipid peroxidation assay was used to compare the antioxidant capacity of baicalin with the flavonoid, epigallocatechin gallate (EGCG). Ischemia/reperfusion to the retina affected the localisation of Thy-1 and choline acetyltransferase (ChAT) and the content of various proteins (optic nerve and retina) and mRNAs (retina). Importantly, baicalin statistically blunted most of the effects induced by ischemia/reperfusion. Only the increase in caspase-8 and caspase-3 mRNAs caused by ischemia/reperfusion were unaffected by baicalin treatment. Baicalin also attenuated significantly the negative insult of light, hydrogen peroxide and serum withdrawal to RGC-5 cells. In the lipid peroxidation studies, baicalin was also found to be equally effective as EGCG to act as an antioxidant. Significantly, the negative insult of serum withdrawal on RGC-5 cell survival was blunted by baicalin but not by EGCG revealing the different properties of the two flavonoids.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0197-0186
pubmed:author
pubmed:issnType
Print
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-37
pubmed:meshHeading
pubmed-meshheading:18835309-Animals, pubmed-meshheading:18835309-Antigens, Thy-1, pubmed-meshheading:18835309-Caspases, pubmed-meshheading:18835309-Cell Survival, pubmed-meshheading:18835309-Cells, Cultured, pubmed-meshheading:18835309-Choline O-Acetyltransferase, pubmed-meshheading:18835309-Culture Media, Serum-Free, pubmed-meshheading:18835309-Flavonoids, pubmed-meshheading:18835309-Hydrogen Peroxide, pubmed-meshheading:18835309-Hypoxia-Ischemia, Brain, pubmed-meshheading:18835309-Injections, Intraperitoneal, pubmed-meshheading:18835309-Lipid Peroxidation, pubmed-meshheading:18835309-Neuroprotective Agents, pubmed-meshheading:18835309-Oxidative Stress, pubmed-meshheading:18835309-Photic Stimulation, pubmed-meshheading:18835309-Rats, pubmed-meshheading:18835309-Reactive Oxygen Species, pubmed-meshheading:18835309-Reperfusion Injury, pubmed-meshheading:18835309-Retinal Ganglion Cells
pubmed:year
2008
pubmed:articleTitle
The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes.
pubmed:affiliation
Nuffield Laboratory of Ophthalmology, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, UK.
pubmed:publicationType
Journal Article